Immunoglobulin M Kappa Heavy And Light Chain Combined
PDE is the FDA product code for Immunoglobulin M Kappa Heavy And Light Chain Combined, a class II device type, regulated under 21 CFR 866.5510. FDA's definition for this code reads: "Intended for the in-vitro quantification of IgM kappa concentration in human serum. The result is to be used with previously diagnosed igm Waldenstoms Macrolobulinaemia, in conjunction with other clinical and laboratory findings". As of , FDA records hold 2 510(k) clearances under this code, the most recent dated , and no recalls.
Classification record
- Product code
- PDE
- Device name
- Immunoglobulin M Kappa Heavy And Light Chain Combined
- FDA definition
- Intended for the in-vitro quantification of IgM kappa concentration in human serum. The result is to be used with previously diagnosed igm Waldenstoms Macrolobulinaemia, in conjunction with other clinical and laboratory findings.
- Regulation
- 21 CFR 866.5510
- Device class
- Class II
- Review panel
- Immunology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 2
- Ingested recalls
- 0
Clearances, product code PDE
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2014 | 1 |
| 2015 | 1 |
Applicants with the most clearances
Product code PDE| Applicant | Clearances |
|---|---|
| The Binding Site Group Ltd. | 2 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
